Back to vendors
L

Latent Health

Visit site
Healthcare agentindependentVerified 2026-07-22

Clinical reasoning engine valued at $600M that ingests doctor's notes, lab results, and imaging reports to answer complex questions about patient history, with AI agents that compile evidence per insurer criteria and call payers for status.

Latent Health is building a clinical reasoning engine: an AI system that ingests data such as doctor's notes, lab results, and imaging reports and answers complex questions about a patient's medical history. Its AI agents compile evidence based on the insurer's criteria and submit prior authorization requests after a human reviews them, and can call insurers on providers' behalf to check request status rather than leaving staff on hold. Co-founded by co-CEO Sriram Somasundaram, the company frames prior authorization as a human compute problem where payers and providers spend hours reviewing the same documents. Valued at $600 million per Forbes coverage in March 2026, with pharmacy and drug access as the initial focus.

Vendor details

Canonical URL

https://www.latenthealth.com

Category

Healthcare agent

Funding status

$600M valuation (Forbes, Mar 2026)

Company status

independent

Use cases & customers

Primary use cases

prior authorization evidence compilationclinical record question answeringpayer status callsdrug access workflows

Target customers

health systemspharmaciesproviders

Deployment options

SaaS

Integrations

Ingests clinical notes, labs, and imaging reports; outbound calls to insurers for status checks; integration catalog not publicly documented.

Capability coverage

5.0 / 14 capabilities · 36%

Integrations & Tool CallingIngests doctor's notes, lab results, and imaging reports; integration catalog not publicly documented, Forbes coverage 2026-07-22 Partial
Workflow OrchestrationAgents compile evidence per insurer criteria, submit requests after human review, and follow up with status calls to insurers, an end to end prior authorization loop, Forbes Mar 2026 coverage 2026-07-22 Full
Knowledge Grounding & RAGThe product is a clinical reasoning engine ingesting notes, labs, and imaging to answer complex questions about patient history against insurer criteria, Forbes coverage 2026-07-22 Full
Human Oversight & GuardrailsRequests are submitted only after a human reviews the compiled evidence, Forbes coverage 2026-07-22 Full
Security, Identity & GovernanceNo security certifications or identity governance documented in retrieved materials, 2026-07-22 Unable to verify
Observability & AuditabilityNo audit trail, reporting console, or decision traceability documented in retrieved materials, 2026-07-22 Unable to verify
Memory & State PersistenceNo documented persistent agent memory capability, retrieved materials 2026-07-22 Unable to verify
Deployment & Data ResidencyEnterprise SaaS; no self host or residency options documented, retrieved materials 2026-07-22 Partial
Prebuilt Agents, Templates & PacksFocused agent suite for prior authorization and drug access workflows; no broader prebuilt agent library documented, Forbes coverage 2026-07-22 Partial
Triggers & Channel CoverageOutbound status calls to insurers are documented, but the trigger surface and broader channel coverage are not documented as first class, Forbes coverage 2026-07-22 Partial
Model Flexibility & RoutingProprietary clinical reasoning engine; no customer facing model choice or routing documented, retrieved materials 2026-07-22 Unable to verify
APIs, SDKs & MCP ExtensibilityNo public developer API, SDK, or MCP surface documented, retrieved materials 2026-07-22 Unable to verify
Testing, Debugging & OptimizationNo customer facing testing or evaluation tooling documented, retrieved materials 2026-07-22 Unable to verify
Browser & Computer UseOperates on clinical documents and phone based status checks, not browser or computer interface control, retrieved materials 2026-07-22 Unable to verify

Pricing

Contact sales

Contact onlyHigh variable cost

What is public

No public pricing. Forbes coverage establishes the $600M valuation and product scope but no commercial terms.

Variable cost rationale

Enterprise pricing scoped to authorization and drug access volume; no public rates.

Sales call required

Yes — required for paid access

Free / trial

None public

Verified 2026-07-22

Contact us

Found a vendor we missed? Have feedback on the index? We'd love to hear from you.